Literature DB >> 7298418

Catheterization of the pulmonary artery in the closed-chest rat.

R B Stinger, V J Iacopino, I Alter, T M Fitzpatrick, J C Rose, P A Kot.   

Abstract

A simple technique has been devised to catheterize the pulmonary artery in rats for measurement of pulmonary artery pressure. A no. 3 1/2 French umbilical vessel catheter (Argyle), angled to 90 degrees over the distal 1 cm, was introduced into the right external jugular vein of the anesthetized (50 mg/kg pentobarbital sodium, ip) rat (male Wistar, 250-350 g). With the angle directed anteriorly, the catheter was inserted 2.5 cm proximally, which placed the catheter in the right atrium. The catheter was rotated 90 degrees counterclockwise and inserted 1.0 cm further, which placed the catheter in the right ventricle. Advancement of the catheter an additional 1.5 cm allowed placement in the pulmonary artery. Placement at each stage was confirmed by the respective pressure contours. This technique is easily and rapidly performed and has many potential applications in measuring parameters of the pulmonary circulation in a variety of small laboratory animals.

Entities:  

Mesh:

Year:  1981        PMID: 7298418     DOI: 10.1152/jappl.1981.51.4.1047

Source DB:  PubMed          Journal:  J Appl Physiol Respir Environ Exerc Physiol        ISSN: 0161-7567


  8 in total

1.  Palosuran treatment effective as bosentan in the treatment model of pulmonary arterial hypertension.

Authors:  Yavuz Pehlivan; Recep Dokuyucu; Tuncer Demir; Davut Sinan Kaplan; Ibrahim Koc; Mustafa Orkmez; Ibrahim Halil Turkbeyler; Ali Osman Ceribasi; Ediz Tutar; Seyithan Taysi; Bunyamin Kisacik; Ahmet Mesut Onat
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

2.  Fasudil and DETA NONOate, Loaded in a Peptide-Modified Liposomal Carrier, Slow PAH Progression upon Pulmonary Delivery.

Authors:  Jahidur Rashid; Kamrun Nahar; Snehal Raut; Ali Keshavarz; Fakhrul Ahsan
Journal:  Mol Pharm       Date:  2018-03-26       Impact factor: 4.939

3.  Inhaled PLGA particles of prostaglandin E₁ ameliorate symptoms and progression of pulmonary hypertension at a reduced dosing frequency.

Authors:  Vivek Gupta; Nilesh Gupta; Imam H Shaik; Reza Mehvar; Eva Nozik-Grayck; Ivan F McMurtry; Masahiko Oka; Masanobu Komatsu; Fakhrul Ahsan
Journal:  Mol Pharm       Date:  2013-03-26       Impact factor: 4.939

4.  Measurement of left ventricular hemodynamic parameters in closed-chest rats under control and various pathophysiologic conditions.

Authors:  H G Zimmer
Journal:  Basic Res Cardiol       Date:  1983 Jan-Feb       Impact factor: 17.165

5.  Urotensin inhibition with palosuran could be a promising alternative in pulmonary arterial hypertension.

Authors:  Ahmet Mesut Onat; Yavuz Pehlivan; Ibrahim Halil Turkbeyler; Tuncer Demir; Davut Sinan Kaplan; Ali Osman Ceribasi; Mustafa Orkmez; Ediz Tutar; Seyithan Taysi; Mehmet Sayarlioglu; Bunyamin Kisacik
Journal:  Inflammation       Date:  2013-04       Impact factor: 4.092

6.  Right heart catheterization in rats with pulmonary hypertension and right ventricular hypertrophy.

Authors:  H G Zimmer; W Zierhut; R C Seesko; A E Varekamp
Journal:  Basic Res Cardiol       Date:  1988 Jan-Feb       Impact factor: 17.165

7.  Bioavailable transition metals in particulate matter mediate cardiopulmonary injury in healthy and compromised animal models.

Authors:  D L Costa; K L Dreher
Journal:  Environ Health Perspect       Date:  1997-09       Impact factor: 9.031

8.  In vivo and in vitro measurements of pulmonary arterial stiffness: A brief review.

Authors:  Lian Tian; Naomi C Chesler
Journal:  Pulm Circ       Date:  2012-10       Impact factor: 3.017

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.